Evidence map›Paper›PMID 36546431›Full record

ArticleHaematologica2023

Sex differences in progression of kidney disease in sickle cell disease.

Kenneth I Ataga, Qingning Zhou, Santosh L Saraf, Jane S Hankins, Emily J Ciccone, Laura R Loehr, Melanie E Garrett, Allison E Ashley-Koch, Jianwen Cai, Marilyn J Telen and 1 more

Open access · goldAbstract readLetter
In one paragraph

Article in Haematologica, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Impact of renal iron overload on sickle cell nephropathy in a humanized mouse model.American journal of physiology. Renal physiology · 2026
    Article
  2. Management of Kidney Disease with Sickle Cell Disease.Journal of the American Society of Nephrology : JASN · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Kenneth I AtagaCenter for Sickle Cell Disease, University of Tennessee Health Scienter Center, Memphis, TN. kataga@uthsc.edu.
Qingning ZhouDepartment of Mathematics and Statistics, University of North Carolina at Charlotte, Charlotte, NC.
Santosh L SarafDivision of Hematology/Oncology, University of Illinois.
Jane S HankinsDepartment of Hematology, St. Jude Children's Research Hospital, Memphis, TN.
Emily J CicconeDivision of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Laura R LoehrDivision of General Medicine and Clinical Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Melanie E GarrettDuke Molecular Physiology Institute, Duke University Medical Center, Durham, NC.
Allison E Ashley-KochDuke Molecular Physiology Institute, Duke University Medical Center, Durham, NC.
Jianwen CaiDepartment of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Marilyn J TelenDivision of Hematology, Duke University Medical Center, Durham, NC.
Vimal K DerebailUNC Kidney Center, Division of Nephrology and Hypertension, University of North Carolina at Chapel Hill, Chapel Hill, NC.
University of North Carolina at Chapel Hill · USDuke Medical Center · USSt. Jude Children's Research Hospital · USUniversity of Illinois Urbana-Champaign · USUniversity of North Carolina at Charlotte · USUniversity of Tennessee Health Science Center · US

Funding

Predicting Progression of Chronic Kidney Disease in Sickle Cell Anemia Using Machine Learning Models (PREMIER)R01HL159376 · NHLBI · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ATAGA, KENNETH I, SARAF, SANTOSH · 2021 to 2025
$3.2M
THE ASSOCIATION OF BIOMARKERS OF ENDOTHELIAL FUNCTION WITH PROSPECTIVE CHANGES IN KIDNEY FUNCTION IN SICKLE CELL ANEMIAR01FD006030 · FDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ATAGA, KENNETH I · 2017 to 2021
$2.0M
Pathways of Cell-Free Hemoglobin in Sickle Cell NephropathyR01HL153161 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SARAF, SANTOSH · 2020 to 2024
$2.0M
FDA HHS R01 FD006030NHLBI NIH HHS R01 HL153161NHLBI NIH HHS R01 HL159376
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anemia, Sickle CellKidney DiseasesDisease ProgressionFemaleHumansKidneyMaleSex Characteristics

Identifiers

PMID36546431
PMCPMC10153522
OpenAlexW4312093792

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.